Cargando…

Longitudinal assessment of quality assurance measurements in a 1.5T MR‐linac: Part I—Linear accelerator

PURPOSE: To describe and report longitudinal quality assurance (QA) measurements for the mechanical and dosimetric performance of an Elekta Unity MR‐linac during the first year of clinical use in our institution. MATERIALS AND METHODS: The mechanical and dosimetric performance of the MR‐linac was ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Subashi, Ergys, Lim, Seng Boh, Gonzalez, Xesus, Tyagi, Neelam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504604/
https://www.ncbi.nlm.nih.gov/pubmed/34505349
http://dx.doi.org/10.1002/acm2.13418
_version_ 1784581353040248832
author Subashi, Ergys
Lim, Seng Boh
Gonzalez, Xesus
Tyagi, Neelam
author_facet Subashi, Ergys
Lim, Seng Boh
Gonzalez, Xesus
Tyagi, Neelam
author_sort Subashi, Ergys
collection PubMed
description PURPOSE: To describe and report longitudinal quality assurance (QA) measurements for the mechanical and dosimetric performance of an Elekta Unity MR‐linac during the first year of clinical use in our institution. MATERIALS AND METHODS: The mechanical and dosimetric performance of the MR‐linac was evaluated with daily, weekly, monthly, and annual QA testing. The measurements monitor the size of the radiation isocenter, the MR‐to‐MV isocenter concordance, MLC and jaw position, the accuracy and reproducibility of step‐and‐shoot delivery, radiation output and beam profile constancy, and patient‐specific QA for the first 50 treatments in our institution. Results from end‐to‐end QA using anthropomorphic phantoms are also included as a reference for baseline comparisons. Measurements were performed in water or water‐equivalent plastic using ion chambers of various sizes, an ion chamber array, MR‐compatible 2D/3D diode array, portal imager, MRI, and radiochromic film. RESULTS: The diameter of the radiation isocenter and the distance between the MR/MV isocenters was (μ ± σ) 0.39 ± 0.01 mm and 0.89 ± 0.05 mm, respectively. Trend analysis shows both measurements to be well within the tolerance of 1.0 mm. MLC and jaw positional accuracy was within 1.0 mm while the dosimetric performance of step‐and‐shoot delivery was within 2.0%, irrespective of gantry angle. Radiation output and beam profile constancy were within 2.0% and 1.0%, respectively. End‐to‐end testing performed with ion‐chamber and radiochromic film showed excellent agreement with treatment plan. Patient‐specific QA using a 3D diode array identified gantry angles with low‐pass rates allowing for improvements in plan quality after necessary adjustments. CONCLUSION: The MR‐linac operates within the guidelines of current recommendations for linear accelerator performance, stability, and safety. The analysis of the data supports the recently published guidance in establishing clinically acceptable tolerance levels for relative and absolute measurements.
format Online
Article
Text
id pubmed-8504604
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-85046042021-10-18 Longitudinal assessment of quality assurance measurements in a 1.5T MR‐linac: Part I—Linear accelerator Subashi, Ergys Lim, Seng Boh Gonzalez, Xesus Tyagi, Neelam J Appl Clin Med Phys Radiation Oncology Physics PURPOSE: To describe and report longitudinal quality assurance (QA) measurements for the mechanical and dosimetric performance of an Elekta Unity MR‐linac during the first year of clinical use in our institution. MATERIALS AND METHODS: The mechanical and dosimetric performance of the MR‐linac was evaluated with daily, weekly, monthly, and annual QA testing. The measurements monitor the size of the radiation isocenter, the MR‐to‐MV isocenter concordance, MLC and jaw position, the accuracy and reproducibility of step‐and‐shoot delivery, radiation output and beam profile constancy, and patient‐specific QA for the first 50 treatments in our institution. Results from end‐to‐end QA using anthropomorphic phantoms are also included as a reference for baseline comparisons. Measurements were performed in water or water‐equivalent plastic using ion chambers of various sizes, an ion chamber array, MR‐compatible 2D/3D diode array, portal imager, MRI, and radiochromic film. RESULTS: The diameter of the radiation isocenter and the distance between the MR/MV isocenters was (μ ± σ) 0.39 ± 0.01 mm and 0.89 ± 0.05 mm, respectively. Trend analysis shows both measurements to be well within the tolerance of 1.0 mm. MLC and jaw positional accuracy was within 1.0 mm while the dosimetric performance of step‐and‐shoot delivery was within 2.0%, irrespective of gantry angle. Radiation output and beam profile constancy were within 2.0% and 1.0%, respectively. End‐to‐end testing performed with ion‐chamber and radiochromic film showed excellent agreement with treatment plan. Patient‐specific QA using a 3D diode array identified gantry angles with low‐pass rates allowing for improvements in plan quality after necessary adjustments. CONCLUSION: The MR‐linac operates within the guidelines of current recommendations for linear accelerator performance, stability, and safety. The analysis of the data supports the recently published guidance in establishing clinically acceptable tolerance levels for relative and absolute measurements. John Wiley and Sons Inc. 2021-09-10 /pmc/articles/PMC8504604/ /pubmed/34505349 http://dx.doi.org/10.1002/acm2.13418 Text en © 2021 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, LLC on behalf of The American Association of Physicists in Medicine https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Radiation Oncology Physics
Subashi, Ergys
Lim, Seng Boh
Gonzalez, Xesus
Tyagi, Neelam
Longitudinal assessment of quality assurance measurements in a 1.5T MR‐linac: Part I—Linear accelerator
title Longitudinal assessment of quality assurance measurements in a 1.5T MR‐linac: Part I—Linear accelerator
title_full Longitudinal assessment of quality assurance measurements in a 1.5T MR‐linac: Part I—Linear accelerator
title_fullStr Longitudinal assessment of quality assurance measurements in a 1.5T MR‐linac: Part I—Linear accelerator
title_full_unstemmed Longitudinal assessment of quality assurance measurements in a 1.5T MR‐linac: Part I—Linear accelerator
title_short Longitudinal assessment of quality assurance measurements in a 1.5T MR‐linac: Part I—Linear accelerator
title_sort longitudinal assessment of quality assurance measurements in a 1.5t mr‐linac: part i—linear accelerator
topic Radiation Oncology Physics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504604/
https://www.ncbi.nlm.nih.gov/pubmed/34505349
http://dx.doi.org/10.1002/acm2.13418
work_keys_str_mv AT subashiergys longitudinalassessmentofqualityassurancemeasurementsina15tmrlinacpartilinearaccelerator
AT limsengboh longitudinalassessmentofqualityassurancemeasurementsina15tmrlinacpartilinearaccelerator
AT gonzalezxesus longitudinalassessmentofqualityassurancemeasurementsina15tmrlinacpartilinearaccelerator
AT tyagineelam longitudinalassessmentofqualityassurancemeasurementsina15tmrlinacpartilinearaccelerator